Recent News

• 11.25.2025 - BridgeBio to Participate in December Investor Conferences
• 11.19.2025 - BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
• 11.08.2025 - Acoramidis Significantly Reduces All-cause Mortality in the Overall ATTR-CM Variant and V142I (V122I) Populations

Recent Filings

• 11.24.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.20.2025 - 144 Report of proposed sale of securities
• 11.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.18.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.18.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.18.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.18.2025 - 144 Report of proposed sale of securities
• 11.17.2025 - 144 Report of proposed sale of securities
• 11.17.2025 - 144 Report of proposed sale of securities